Specific IgG4/IgE response after rapid desensitization to low-dose oral immunotherapy with adjunct omalizumab in multi-food allergic patients

• Sayantani B. Sindher,
• Andrew Long,
• Natasha Purington,
• Divya Kumar,
• Stacey Skura,
• Margaret A. Woch,
• Tiffany Tan,
• Andres Alvarez,
• R. Sharon Chinthrajah,
• Maria Garcia-Lloret,
• Kari C. Nadeau

Affiliations

Sayantani B. Sindher

Stanford University - School of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford, CA, USA

Andrew Long

Stanford University - School of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford, CA, USA

Natasha Purington

Stanford University - School of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford, CA, USA

Divya Kumar

Stanford University - School of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford, CA, USA

Stacey Skura

UCLA - School of Medicine, Division of Allergy, Immunology & Rheumatology, Department of Pediatrics David Geffen, Los Angeles, CA, USA

Margaret A. Woch

Stanford University - School of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford, CA, USA

Tiffany Tan

Stanford University - School of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford, CA, USA

Andres Alvarez

Stanford University - School of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford, CA, USA

R. Sharon Chinthrajah

Stanford University - School of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford, CA, USA

Maria Garcia-Lloret

UCLA - School of Medicine, Division of Pediatric Allergy/Immunology and Rheumatology, Department of Pediatrics, Los Angeles, CA, USA

Kari C. Nadeau

Stanford University - School of Medicine, Sean N. Parker Center for Allergy and Asthma Research, Stanford, CA, USA